Effects of medication on dopamine transporter imaging using [I]I-FP-CIT SPECT in routine practice.
Fiche publication
Date publication
décembre 2023
Journal
European journal of nuclear medicine and molecular imaging
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VERGER Antoine
Tous les auteurs :
Piatkova Y, Doyen M, Heyer S, Tahmazov A, Frismand S, Hopes L, Imbert L, Verger A
Lien Pubmed
Résumé
Dopamine transporter (DAT) imaging is used to support the diagnosis of neurodegenerative parkinsonian disorders. Specific medications have been reported to confound the interpretation of [I]I-FP-CIT SPECT scans, but there is limited data. The aim of the current study is to identify potential medication effects on the interpretation of [I]I-FP-CIT SPECT scans in routine practice.
Mots clés
Antidepressants, DAT, Dopaminergic imaging, Drugs, FP-CIT, NASSA, Parkinson’s disease
Référence
Eur J Nucl Med Mol Imaging. 2023 12 20;: